Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Aleksander Bagaev"'
Autor:
Danilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, Nikita Kotlov, Maria Sorokina, Jude Phillip, Paul Zumbo, Liron Yoffe, Han Xueshuai, Claudia Pignataro, Paola Ghione, Valentina Fragliasso, Gerolama Condorelli, Robin Foà, Joshua Brody, Doron Betel, Wing C Chan, Wayne Tam, Anastasie Nikitina, Aleksander Bagaev, Nathan Fowler, David Weinstock, Leandro Cerchietti, Raul Rabadan, Steve Horwitz, Giorgio Inghirami
Publikováno v:
HemaSphere, Vol 7, p e8686389 (2023)
Externí odkaz:
https://doaj.org/article/ac0ba3f3a2254b25bcc9944460c428ab
Autor:
Yuanyuan Zha, Xiufen Chen, James Godfrey, Girish Venkataraman, Justin P Kline, Aleksander Bagaev, Jovian Yu, Nicole Sunseri, Alan Cooper, Arina Varlamova, Dmitry Zarubin, Yuriy Popov, Connor Jacobson, Ekaterina Postovalova, Zhongmin Xiang, Krystle Nomie, Sravya Tumuluru, Sonali M Smith
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background PD-1 checkpoint blockade therapy (CBT) has greatly benefited patients with select solid tumors and lymphomas but has limited efficacy against diffuse large B-cell lymphoma (DLBCL). Because numerous inhibitory checkpoint receptors have been
Externí odkaz:
https://doaj.org/article/4f9de0e70e7e43809db62f8d3b1fab29
Autor:
Yan Zhang, Zhenglu Wang, Cassian Yee, Patrick Hwu, Chantale Bernatchez, Jason Roszik, Roland Bassett, Marie-Andree Forget, Minying Zhang, Michael A Davies, Gregory Lizee, Ling Han, Fenge Li, Ligang Deng, Kyle R Jackson, Amjad H Talukder, Arjun S Katailiha, Sherille D Bradley, Qingwei Zou, Caixia Chen, Chong Huo, Yulun Chiu, Matthew Stair, Weihong Feng, Aleksander Bagaev, Nikita Kotlov, Viktor Svekolkin, Ravshan Ataullakhanov, Natalia Miheecheva, Felix Frenkel, Yaling Wang, David Hawke, Shuo Zhou, William K Decker, Heather M Sonnemann, Xueming Du
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Neoantigen (NeoAg) peptides displayed at the tumor cell surface by human leukocyte antigen molecules show exquisite tumor specificity and can elicit T cell mediated tumor rejection. However, few NeoAgs are predicted to be shared between pa
Externí odkaz:
https://doaj.org/article/ac1fa606444a418b80b726080cf67799
Autor:
Elena Ocheredko, Nadezhda Lukashevich, Maria Savchenko, Sofia Kust, Syune Ambaryan, Dmitry Tabakov, Maria Sorokina, Linda Balabanian, Kushal Suryamohan, Anastasiya Zotova, Nathan Fowler, Aleksander Bagaev
Publikováno v:
Cancer Research. 83:6538-6538
Functional gene expression signatures (FGES) are widely used as biomarkers in cancer diagnostics as descriptive and predictive models for treatment selection. Since FGES scores are based solely on gene expression profiles, they can be applied to data
Autor:
Zou Qingwei, Ling Han, William K. Decker, Chong Huo, Nikita Kotlov, Michael A. Davies, Cassian Yee, David H. Hawke, Kyle R. Jackson, Gregory Lizée, Caixia Chen, Shuo Zhou, Arjun S. Katailiha, Zhenglu Wang, Deng Ligang, Chantale Bernatchez, Amjad H. Talukder, Wang Yaling, Yulun Chiu, Minying Zhang, Natalia Miheecheva, Felix Frenkel, Matthew Stair, Yan Zhang, Weihong Feng, Jason Roszik, Xueming Du, Patrick Hwu, Aleksander Bagaev, Marie Andrée Forget, Sherille D. Bradley, Roland L. Bassett, Viktor Svekolkin, Ataullakhanov Ravshan I, Fenge Li, Heather M. Sonnemann
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundNeoantigen (NeoAg) peptides displayed at the tumor cell surface by human leukocyte antigen molecules show exquisite tumor specificity and can elicit T cell mediated tumor rejection. However, few NeoAgs are predicted to be shared between pat
Autor:
Ivan Valiev, Nikita Kotlov, Anna Belozerova, Aleksandra Lopareva, Anna Butusova, Naira Samarina, Alexandra Boiko, Sandrine Degryse, Lecia Sequist, Mari Mino-Kenudson, Nathan Fowler, Aleksander Bagaev, Michael Lanuti, Ibiayi Dagogo-Jack
Publikováno v:
Cancer Research. 82:5172-5172
In non-small cell lung cancer (NSCLC), likelihood of cure is heavily influenced by stage at diagnosis. In contrast to stage I where surgery achieves cure for >70% of patients, the majority of patients with stage II NSCLC will develop recurrent diseas
Autor:
Dmitry Zarubin, Valeriy Belotskiy, Zhongmin Xiang, Arina Varlamova, Pavel Ovcharov, Ilia Galkin, Margarita Polyakova, Viktor Svekolkin, Grigory Perelman, Maria Bruttan, Jessica H. Brown, Ekaterina Postovalova, Aleksander Bagaev, Nathan Fowler
Publikováno v:
Journal of Clinical Oncology. 40:3020-3020
3020 Background: Understanding the underlying heterogeneity of the tumor microenvironment (TME) on a single-cell level is becoming increasingly important to predict a patient’s response to immunotherapy. Conventional imaging methods can help reveal
Autor:
Prashant V. Thakkar, Sandipto Sarkar, Navjot Kaur, Olga Plotnikova, Olivier Elemento, Dina Elmonshed, Aleksander Bagaev, Andrew H. Ko, Doron Betel, Meredith E. Pittman, Peter C. Enzinger, Nikita Kotlov, Bhavneet Bhinder, Philip A. Philip, Heinz-Josef Lenz, Kyle Cleveland, Manish A. Shah, Chao Zhang, Allyson J. Ocean, Paraskevi Giannakakou, Yao Lu, Paul J. Christos, Felix Frenkel, Giuseppe Galletti, Jeremy S. Kortmansky
Publikováno v:
Clin Cancer Res
Purpose:We examined cabazitaxel, a novel next-generation taxoid, in patients with metastatic gastric cancer in a multicenter phase II study.Patients and Methods:Patients who have progressed on one or more prior therapies for locally advanced, unresec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f8e198339b605bbbf676ab323992a58
https://europepmc.org/articles/PMC8209413/
https://europepmc.org/articles/PMC8209413/
Autor:
Ben George, Samih Thalji, Subramaniam Malarkannan, Olga Kudryashova, Andrey Kravets, Mariia Gusakova, Dmitry Kravchenko, Dmitry Tychinin, Felix Frenkel, Aleksander Bagaev, Nara Shin, Maahum Mehdi, Mandana Kamgar, William A. Hall, Beth Erickson, Kathleen K. Christians, Douglas B. Evans, Susan Tsai
Publikováno v:
Journal of Clinical Oncology. 40:589-589
589 Background: Spatiotemporal heterogeneity, paucity of actionable targets, and complexity of the tumor microenvironment (TME) are major barriers to therapeutic advances in pancreatic ductal adenocarcinoma (PDAC). We reconstructed the transcriptomic
Autor:
Prashant K. Thakkar, Meredith E. Pittman, Olga Plotnikova, Chao Zhang, Yao Lu, Heinz Joseph Lenz, Nikita Kotlov, Bhavneet Bhinder, Allyson J. Ocean, Peter C. Enzinger, Sandipto Sarkar, Feliz Frenkel, Doron Betel, Olivier Elemento, Paraskevi Giannakakou, Manish A. Shah, Aleksander Bagaev, Andrew H. Ko
Publikováno v:
Cancer Research. 80:2011-2011
Gastric cancer (GC), responsible for ~700,000 deaths worldwide annually, is a dismal disease, with median survival for metastatic disease less than 1 year. We examined the efficacy and safety of cabazitaxel, a novel 3rd generation taxane, in the 2nd